Press Releases

Summary ToggleIntriCon Reports First Quarter 2020 Results

ARDEN HILLS, Minn. , May 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2020 . Read More

Summary ToggleIntriCon Acquires Emerald Medical Services

Synergistic joint development and manufacturing capability expands market opportunity in surgical navigation Provides immediate access to technology platform serving new high growth medical end-markets with complex interventional catheters   Accretive transaction delivers long-term revenue growth Read More

Summary ToggleINTRICON OFFERS COVID-19 RELATED BUSINESS UPDATE

Provides Preliminary First Quarter 2020 Results; Withdraws Full Year 2020 Guidance ARDEN HILLS, Minn. , April 07, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today Read More